This review summarizes the current applications of single-cell and spatial transcriptomics in renal regeneration and fibrosis and introduces emerging technologies, such as proximity-dependent labeling, while rarely applied in kidney research to date, hold significant potential.
Abstract
Abstract Background Kidney diseases, which are broadly classified into acute kidney injury (AKI) and chronic kidney disease (CKD), represent a significant and ongoing health burden in China and across the globe. AKI is a clinical syndrome marked by a rapid decline in renal function within 48 h due to diverse causes. Despite its high prevalence among hospitalized patients as a common complication, current therapeutic outcomes remain unsatisfactory. Therefore, a critical step toward resolving this issue is the precise identification of the specific cell types that drive renal regeneration during AKI repair. Renal fibrosis, pathologically characterized by excessive extracellular matrix (ECM) deposition, is the common final pathway of CKD and significantly impairs patient’s quality of life and prognosis. The focal nature of fibrotic lesions has prompted systematic investigations into the fibrotic microenvironment. Myofibroblasts are the central effector cells driving pathological ECM deposition. Nevertheless, their cellular origins remain elusive. A thorough understanding of myofibroblast origins, along with the composition and regulatory factors of the fibrotic microenvironment, is therefore crucial for developing effective treatments for renal fibrosis. Summary The kidney is a complex organ with intricate anatomical structures and diverse cellular composition. Traditional investigative methods which rely on conventional pathology and low-resolution molecular biology have been unable to capture cellular heterogeneity at single-cell resolution. This limitation has obscured functional distinctions among cell subpopulations and their critical spatial context, thereby leading to an inadequate understanding of intercellular communication. Fortunately, the advent of single-cell and spatial transcriptomics has revolutionized kidney research by enabling comprehensive profiling of functional signatures and intercellular crosstalk within the renal microenvironment. Key Messages This review summarizes the current applications of single-cell and spatial transcriptomics in renal regeneration and fibrosis. Furthermore, it introduces emerging technologies, such as proximity-dependent labeling, while rarely applied in kidney research to date, hold significant potential. Our aim is to provide researchers with insightful strategies for their future application in this field.
INTRODUCTION
Acute kidney injury (AKI) is a severe clinical syndrome associated with high morbidity and mortality, and it possesses high risk of progression to chronic kidney disease (CKD). Renal infiltration of inflammatory cells, particularly macrophages, plays a key role in driving the progression from AKI to CKD....
Liuyan Xiao, Yinyi Long, Xue Hong et al.· Journal of Advanced Research· 0 citations
Renal fibrosis is a final common pathway in chronic kidney disease (CKD), yet available therapies rarely reverse established scarring. T lymphocytes are now recognized as dynamic regulators of this process rather than simple inflammatory bystanders. This Review integrates evidence from experimental kidney injury models...
Qian-Hui Li, Jun-Ting Guan, Yi-Fan Song et al.· Advancement of science· 0 citations
A theoretical basis is provided for understanding the pathogenesis of fibrosis and developing precision treatment strategies based on macrophage heterogeneity, as well as the therapeutic potential of targeting macrophage metabolic pathways, phenotypic transitions, and the elimination of specific subpopulations.
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease (ESKD), and while current standard treatment strategies can slow disease progression, they are still unable to reverse progressive structural damage to the kidneys. Emerging evidence indicates that the senescence of renal tubular epithelial ce...
Jun-Wei Shi, Jia-Ning Sun, Jun-Wei Gao et al.· Frontiers in Cell and Develo...· 0 citations
Acute interstitial nephritis (AIN) is present in 15-20% of all acute kidney injury cases but lacks proven effective therapies beyond corticosteroids. Using high-resolution imaging mass cytometry and single-cell spatial transcriptomics to analyze human kidney biopsies with AIN, acute tubular injury (ATI), and reference...
Megan L. Baker, Vijayakumar R. Kakade, Tifanny Budiman et al.· Nature Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.